POULTRY 
Autogenous Vaccines
Autogenous vaccines make it possible to have a unique and constantly updated combination by selecting specific strains in the field.
These “custom-made” vaccines have become an essential weapon against the repeated use of antibiotics on infected farms, especially in the poultry sectors, where the current policy requires reduced and rational antibiotic use.
What are autogenous vaccines
Autogenous vaccines are made from bacterial or viral isolates (pathogens or antigens) taken from infected flocks on the same farm.
These inactivated vaccines are used on other flocks on the same and neighboring farms to stimulate immunity to that particular isolate.
Do you have questions?
Contact usAdvantages of autogenous vaccines
Veterinarians and animal health managers use autogenous vaccines when there is no suitable vaccine available (eg. Adenovirus, Astrovirus, Riemerella, etc.) or in addition to commercial vaccine programs. They are also useful when the bacterial or viral agents have a broad antigen variability (eg. E.coli, Reovirus, etc.).
Autogenous Vaccine Services at Ceva
Cevac Biovac in France, and Ceva Lenexa in the USA are established centers with over two decades of expertise in autogenous vaccine development and production. Their vaccines have been crucial in enhancing vaccination programs, protecting millions of poultry across the Americas, Europe, and parts of Africa and Asia annually. In partnership with Filavie (France) viral autogenous vaccines are crafted to serve the European, Asian, and Latin American markets. These vaccines play a significant role in promoting Antibiotic-free (ABF) production and advancing health and welfare within the poultry industry.
